(Q43439663)

English

Apoptosis and TRAF-1 cleavage in Epstein-Barr virus-positive nasopharyngeal carcinoma cells treated with doxorubicin combined with a farnesyl-transferase inhibitor

scientific article published in February 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Apoptosis and TRAF-1 cleavage in Epstein-Barr virus-positive nasopharyngeal carcinoma cells treated with doxorubicin combined with a farnesyl-transferase inhibitor (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Epstein–Barr virus

0 references

1 reference

based on heuristic

inferred from title

8

object named as

Paule Opolon

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Hector Ardila-Osorio

2

object named as

Hector Ardila-Osorio

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

author name string

Jean Michel Vicat

1

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Abdelmajid Khabir

3

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Marie Christine Brezak

4

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Isabelle Viossat

5

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Philip Kasprzyk

6

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Rachid Jlidi

7

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Tadamassa Ooka

9

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Grégoire Prevost

10

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Dolly P Huang

11

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Pierre Busson

12

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

language of work or name

0 references

publication date

1 February 2003

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Biochemical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

65

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

423-433

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

High level expression of deltaN-p63: a mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma (NPC)?

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901449-1

7 January 2021

Apoptosis in nasopharyngeal carcinoma as related to histopathological characteristics and clinical stage

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901449-1

7 January 2021

Induction chemotherapy followed by alternating chemo-radiotherapy in stage IV undifferentiated nasopharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901449-1

7 January 2021

Patterns of failure after induction chemotherapy and radiotherapy for locoregionally advanced nasopharyngeal carcinoma: the Queen Mary Hospital experience

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901449-1

7 January 2021

Establishment and characterization of three transplantable EBV-containing nasopharyngeal carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901449-1

7 January 2021

Two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus that were derived from nasopharyngeal carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901449-1

7 January 2021

Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901449-1

7 January 2021

Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901449-1

7 January 2021

Cytogenetic studies in three xenografted nasopharyngeal carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901449-1

7 January 2021

Characterization of a new EBV-associated nasopharyngeal carcinoma cell line.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901449-1

7 January 2021

Cisplatin chemotherapy plus adenoviral p53 gene therapy in EBV-positive and -negative nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901449-1

7 January 2021

Inhibitors of anchorage-independent growth affect the growth of transformed cells on poly(2-hydroxyethyl methacrylate)-coated surfaces

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901449-1

7 January 2021

Heterogeneity of HLA and EBER expression in Epstein-Barr virus-associated nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901449-1

7 January 2021

Inhibition of human tumor cell growth in vitro and in vivo by a specific inhibitor of human farnesyltransferase: BIM-46068

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901449-1

7 January 2021

Inhibition of human tumor cell growth in vivo by an orally bioavailable inhibitor of human farnesyltransferase, BIM-46228.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901449-1

7 January 2021

TRAF1 is a negative regulator of TNF signaling. enhanced TNF signaling in TRAF1-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901449-1

7 January 2021

The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901449-1

7 January 2021

Evidence of LMP1-TRAF3 interactions in glycosphingolipid-rich complexes of lymphoblastoid and nasopharyngeal carcinoma cells

2 references

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901449-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901449-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Activation of MAD 2 checkprotein and persistence of cyclin B1/CDC 2 activity associate with paclitaxel-induced apoptosis in human nasopharyngeal carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901449-1

7 January 2021

Apoptosis induced by low-dose paclitaxel is associated with p53 upregulation in nasopharyngeal carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901449-1

7 January 2021

Induction chemotherapy with mitomycin, epirubicin, cisplatin, fluorouracil, and leucovorin followed by radiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901449-1

7 January 2021

Farnesyltransferase and geranylgeranyltransferase I inhibitors and cancer therapy: lessons from mechanism and bench-to-bedside translational studies

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901449-1

7 January 2021

Farnesyltransferase inhibitors: antineoplastic properties, mechanisms of action, and clinical prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901449-1

7 January 2021

Farnesyl transferase inhibitors cause enhanced mitotic sensitivity to taxol and epothilones

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901449-1

7 January 2021

Identification and classification of p53-regulated genes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901449-1

7 January 2021

Daunorubicin- and mitoxantrone-triggered phosphatidylcholine hydrolysis: implication in drug-induced ceramide generation and apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901449-1

7 January 2021

Expression of the tumour necrosis factor receptor-associated factors 1 and 2 in Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901449-1

7 January 2021

Frequent expression of the tumor necrosis factor receptor-associated factor 1 in latent membrane protein 1-positive posttransplant lymphoproliferative disease and HIV-associated lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901449-1

7 January 2021

Identification of a novel protein encoded by the BamHI A region of the Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901449-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0006-2952(02)01449-1

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43439663&oldid=1988874458"